SEGERA TERBIT
Penulis: Achmad Rafli, Dwi Putro Widodo, Ivan Riyanto Widjaja
PEDIATRIC Essential Neuropharmacology 2025 serves as a comprehensive clinical guide designed to support healthcare professionals, pharmacists, and medical students in selecting and managing neurological medications in pediatric patients.
This evidence-based volume offers in-depth insights into the pharmacological management of central nervous system disorders in children, covering a wide range of conditions including epilepsy, ADHD, sleep disorders, neuropathic pain, and neurodegenerative diseases.
Each chapter provides practical information on:
- Drug selection criteria tailored to the child’s age, weight, and clinical condition,
- Optimal dosing strategies based on pediatric pharmacokinetics and pharmacodynamics,
- Common and rare side effects, and
- Guidelines for drug interactions, tapering, and therapy transitions.
Enhanced with summary tables, clinical algorithms, and real-world case studies, this book is an essential reference for making safe, effective, and individualized treatment decisions in pediatric neuropharmacology.
PEDIATRIC Essential Neuropharmacology 2025 bridges the gap between foundational science and clinical practice—offering a reliable roadmap for navigating the complexities of neurologic drug therapy in children.
